Patients who are hypersensitive to this drug or to any ingredient in the formulation or component of the container.
There are no available data on Lifitegrast use in pregnant women to inform any drug associated risks. There are no data on the presence of Lifitegrast in human milk, the effects on the breastfed infant or the effects on milk production.
Do not touch the dropper tip to surfaces since this may contaminate the solution. After one month of the opening do not use the medicine of dropper.
Pediatric Use: Safety and efficacy in pediatric patients below the age of 17 years have not been established.
Geriatric Use: No overall differences in safety or effectiveness have been observed between elderly and younger adult patients.
There is no information regarding overdose in patients taking Lifitegrast. For management of a suspected drug overdose, contact your ophthalmologist.
Other ophthalmic preparations
Store in a cool (below 30°C) and dry place, away from light. Keep out of the reach of children.